Atlas Trials

Safety and Pharmacokinetic Study of Oral ON 01910.Na in Patients With Myelodysplastic Syndrome

Clinical trial NCT01048619 · COMPLETED

Trial details

NCT number
NCT01048619
Sponsor
Traws Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndrome
Start date
2009-12-01
Primary completion
2014-11-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.